artificial intelligence
AI image analysis is changing cellular biology
Artificial intelligence is transforming our understanding of cell biology — merging molecular and cellular data to better understand how various cell processes work. Images are a gold mine that can yield information as rich as the genome, STAT's Angus Chen writes, once you learn how to extract it.
Researchers like Anne Carpenter, an AI and cell biology researcher at the Broad Institute, and Cambridge Stem Cell Institute professor Sarah Teichmann spoke of the potential at the STAT Summit last week in Boston.
"We're firmly in the spatial era for in vivo human cell and tissue characterization," said Teichmann, who co-founded the international Human Cell Atlas Consortium. "One of the exciting things is to be able to connect molecular data to more cellular morphological data and tissue morphology."
Read more.
drug pricing
Controversy around 340B drug discount program
The 340B drug discount program was launched in 1992 to cut drug costs for hospitals and clinics serving low-income patients. A new analysis shows that last year the program grew 23.4%, with $63 billion in purchases, STAT's Ed Silverman writes. The growth is intensifying the conflict between the pharmaceutical and hospital industries, with drugmakers restricting discounts saying they're being abused.
"The data spotlight the increasing gulf between the growth of the 340B and the lack of any evidence that patients are benefitting from those discounts," one pricing consult told STAT.
Read more.
No comments